Greg is the former Chief Executive Officer of GNG Group LLC.

​

Under Greg’s leadership, GNG was formed in 2010 and shortly thereafter reached seven-figure sales revenues. Now more than a decade later, with Greg as CEO, the GNG Group continues to deliver innovative solutions and value to its clients and stakeholders.

​

Greg is a marketing and sales analytics leader and innovator with over 30 years of Pharmaceutical industry experience. He has been a key driver of numerous new product marketing introductions, 13 of which achieved sales greater than $1 billion. Working for several multi-billion-dollar organizations, including GlaxoSmithKline and Novartis, Greg has held key commercial analytics and leadership roles.

​

In addition to his extensive commercial corporate expertise, Greg is a successful entrepreneur, who conceived of, funded, built and sold several successful analytics-based businesses.

Greg graduated on the National Honor Society from Philadelphia’s Northeast High School and received his bachelor’s degree from The Pennsylvania State University in both Computer Science and Quantitative Business Analysis.